Can immune cell changes affect liver transplant outcomes from Ischemia-Reperfusion Injury?

Liver transplant outcomes are heavily influenced by ischemia-reperfusion injury (IRI), which occurs when blood flow returns to the organ after a period of low oxygen. Research shows that immune cells and gut bacteria play a critical role in how severe this injury becomes. When blood flow is restored, these cells can release inflammatory signals that damage the new liver tissue, leading to poor graft function and survival.

What the research says

Studies indicate that the patient's systemic metabolic state changes how immune cells use energy, and these changes directly determine the severity of rejection and ischemia-reperfusion injury ³. Specifically, the restoration of blood flow activates the innate immune system through reactive oxygen species, which then regulates cell death and impairs organ function ⁶. This process involves specific immune cells like Kupffer cells, which are stimulated by bacterial products moving from the gut to the liver, causing inflammation that harms hepatocytes ⁷.

The injury is further complicated by a unique cell death process called PANoptosis, which combines features of pyroptosis, apoptosis, and necroptosis. This integrated mode of cell death plays a significant regulatory role in the occurrence of ischemia-reperfusion injury and contributes to the dysfunction of the transplanted organ ⁴. Additionally, aging livers show significant differences in immune cell composition compared to young livers, making them more susceptible to this type of injury during transplantation ⁵.

What to ask your doctor

• How might my specific immune cell metabolism affect my risk for ischemia-reperfusion injury?
• Could my gut microbiota composition influence the inflammation levels in my new liver graft?
• Are there treatments available to target specific cell death pathways like PANoptosis to protect my transplant?
• What steps can we take to manage the metabolic changes in my immune cells after surgery?